Axillary Skin Fibroblast Activation Protein Uptake After Chemo-immunotherapy on PET/CT and SPET/CT: A Mere Coincidence or Causality?
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 39994903.
- Also identified by DOI 10.1097/RLU.0000000000005783.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fibroblast activation protein (FAP) uptake can occur in benign conditions in addition to malignancies. This case series presents the first evidence of diffuse FAP uptake in axillary skin on PET/CT and SPET/CT of 33 patients with progressive solid tumors, referred to peptide-targeted radionuclide therapy after failing prior chemotherapy and/or immunotherapy. Upon physical examination, no significant findings were observed in the axillary regions. We hypothesize that fibroblastic activation may involve sweat glands consequently to systemic therapy, although the reason why the axillary site is favored is not known. Being common in this clinical setting, proper interpretation of this sign is needed.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Skin
- Immunotherapy
- Axilla
- Serine Endopeptidases
- Membrane Proteins
- Gelatinases
- Single Photon Emission Computed Tomography Computed Tomography